Clinical Trials Insight: 700034255
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 06 Jun 2008
At a glance
- Drugs Ondansetron (Primary)
- Indications Nausea; Vomiting
- Focus Pharmacokinetics; Registrational
- Sponsors Par Pharmaceutical Companies
- 06 Jun 2008 New trial record.
- 08 May 2008 Expect to file and NDA by end of year 2008.